scPharmaceuticals’ (NASDAQ:SCPH) quiet period will end on Wednesday, December 27th. scPharmaceuticals had issued 6,400,000 shares in its public offering on November 17th. The total size of the offering was $89,600,000 based on an initial share price of $14.00. During scPharmaceuticals’ quiet period, underwriters and any insiders that worked on the IPO are prevented from issuing any earnings forecasts or research reports for the company because of SEC regulations. Following the end of the company’s quiet period, it’s expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.

A number of analysts recently weighed in on the company. BMO Capital Markets assumed coverage on scPharmaceuticals in a research report on Tuesday, December 12th. They issued an “outperform” rating and a $24.00 target price for the company. Jefferies Group assumed coverage on scPharmaceuticals in a research report on Tuesday, December 12th. They issued a “buy” rating and a $23.00 target price for the company. Finally, Leerink Swann assumed coverage on scPharmaceuticals in a research report on Tuesday, December 12th. They issued an “outperform” rating and a $20.00 target price for the company.

scPharmaceuticals (NASDAQ:SCPH) opened at $11.80 on Friday. scPharmaceuticals has a 12 month low of $11.80 and a 12 month high of $18.17.

In related news, major shareholder 5Am Partners Iv, Llc purchased 654,762 shares of the firm’s stock in a transaction on Tuesday, November 21st. The shares were acquired at an average cost of $14.00 per share, with a total value of $9,166,668.00. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website.

WARNING: “scPharmaceuticals, Inc.’s (SCPH) Quiet Period Will End on December 27th” was published by Daily Political and is owned by of Daily Political. If you are viewing this piece of content on another site, it was copied illegally and republished in violation of U.S. and international copyright and trademark legislation. The original version of this piece of content can be viewed at https://www.dailypolitical.com/2017/12/21/scpharmaceuticals-inc-s-scph-quiet-period-will-end-on-december-27th.html.

scPharmaceuticals Company Profile

scPharmaceuticals, Inc, is a biopharmaceutical company. The Company is engaged in developing pharmaceutical products for subcutaneous delivery. The Company offers sc2Wear Infusor, which is a small pump that attaches to the body using a standard medical adhesive. The sc2Wear Infusor injects the drug into the body slowly, similar to an intravenous (IV) drip.

Receive News & Ratings for scPharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for scPharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.